The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Enzo Médico(Candiolo Cancer Institute), Alberto Bardelli(Candiolo Cancer Institute)
Cited by 305
Related Papers
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
|Nature Medicine|2022|251
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
|Nature Communications|2016|211
Exploiting <scp>DNA</scp> repair defects in colorectal cancer
|Molecular Oncology|2019|134
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
|Nature Communications|2015|128
TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells
|Clinical Cancer Research|2014|114